Jiangsu Kanion Pharmaceutical Co.,Ltd. (600557.SS)
CNY 14.27
(0.35%)
CNY 14.27
(0.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.86 Billion | 4.35 Billion | 3.64 Billion | 3.03 Billion | 4.56 Billion | 3.82 Billion |
| Cost of Revenue | 1.25 Billion | 1.21 Billion | 1.02 Billion | 821.68 Million | 998.91 Million | 904.94 Million |
| Gross Profit | 3.61 Billion | 3.13 Billion | 2.62 Billion | 2.21 Billion | 3.56 Billion | 2.91 Billion |
| Operating Expenses | 3.04 Billion | 2.69 Billion | 2.27 Billion | 1.84 Billion | 2.95 Billion | 2.38 Billion |
| Selling, General and Administrative Expenses | 2.11 Billion | 1.95 Billion | 1.64 Billion | 1.36 Billion | 2.35 Billion | 1.93 Billion |
| Research and Development Expenses | 737.99 Million | 605.73 Million | 499.38 Million | 380.42 Million | 442.63 Million | 292.78 Million |
| Other Expenses | 196.44 Million | 137.93 Million | 127.72 Million | 99.74 Million | 159.48 Million | -4.62 Million |
| Cost and Expenses | 4.3 Billion | 3.9 Billion | 3.29 Billion | 2.66 Billion | 3.95 Billion | 3.28 Billion |
| Operating Income | 563.79 Million | 454.81 Million | 350.98 Million | 351.42 Million | 578.91 Million | 500.62 Million |
| Interest Expense | 1.45 Million | 1.91 Million | 11.15 Million | 23.46 Million | 38.97 Million | 44.29 Million |
| Income Tax Expense | 3.93 Million | 3.79 Million | 3.91 Million | 20.39 Million | 58.84 Million | 58.4 Million |
| Earnings before Tax | 550.98 Million | 445.71 Million | 328.26 Million | 294.42 Million | 575.35 Million | 496 Million |
| Net Income | 536.73 Million | 434.46 Million | 320.54 Million | 262.92 Million | 506.99 Million | 431.38 Million |
| Earnings Per Share Basic | 0.93 | 0.75 | 0.56 | 0.44 | 0.86 | 0.73 |
| Earnings Per Share Diluted | 0.93 | 0.75 | 0.56 | 0.44 | 0.86 | 0.73 |
| Weighted Average Shares Outstanding | 577.13 Million | 576.31 Million | 576.42 Million | 592.88 Million | 592.88 Million | 591.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 577.13 Million | 576.31 Million | 576.42 Million | 592.88 Million | 592.88 Million | 591.5 Million |
| Gross Margin | 0.74 | 0.72 | 0.72 | 0.73 | 0.78 | 0.76 |
| EBIT Margin | 0.15 | 0.15 | 0.14 | 0.16 | 0.17 | 0.18 |
| Profit Margin | 0.11 | 0.10 | 0.09 | 0.09 | 0.11 | 0.11 |
| EBITDA | 743.16 Million | 637.46 Million | 531.11 Million | 478.98 Million | 782.14 Million | 692.76 Million |
| Earnings Before Tax Margin | 0.12 | 0.10 | 0.10 | 0.12 | 0.13 | 0.13 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 849.73 Million | 887.02 Million | 1.35 Billion | 4.79 Billion | 1.35 Billion | 942.86 Million |
| Cost of Revenue | 226.92 Million | 250.79 Million | 345.11 Million | 1.33 Billion | 356.24 Million | 280.17 Million |
| Gross Profit | 622.81 Million | 636.23 Million | 1.01 Billion | 3.45 Billion | 995.33 Million | 662.68 Million |
| Operating Expenses | 518.6 Million | 553.32 Million | 845.74 Million | 2.96 Billion | 891.19 Million | 571.72 Million |
| Selling, General and Administrative Expenses | 659.66 Million | 426.79 Million | 625.37 Million | - | 636.54 Million | 490.24 Million |
| Research and Development Expenses | 127.54 Million | 126.53 Million | 204.12 Million | - | 251.87 Million | 146.55 Million |
| Other Expenses | -268.6 Million | 9.29 Million | -4.99 Million | 5.13 Million | -2.77 Million | -4.53 Million |
| Cost and Expenses | 745.53 Million | 804.11 Million | 1.19 Billion | 4.3 Billion | 1.24 Billion | 851.89 Million |
| Operating Income | 109.78 Million | 82.9 Million | 182.59 Million | 489.85 Million | 104.14 Million | 104.83 Million |
| Interest Expense | - | - | - | 1.45 Million | - | - |
| Income Tax Expense | 17.75 Million | 17.48 Million | 28.03 Million | 3.93 Million | -71.35 Million | 23.43 Million |
| Earnings before Tax | 110.44 Million | 139.2 Million | 177.6 Million | 550.96 Million | 115.93 Million | 100.29 Million |
| Net Income | 91.72 Million | 117.37 Million | 148.04 Million | 536.73 Million | 187.2 Million | 73.8 Million |
| Earnings Per Share Basic | 0.16 | 0.20 | 0.26 | - | 0.32 | 0.13 |
| Earnings Per Share Diluted | 0.16 | 0.20 | 0.25 | - | 0.32 | 0.13 |
| Weighted Average Shares Outstanding | 569.45 Million | 572.87 Million | 569.4 Million | 577.13 Million | 578.44 Million | 576.42 Million |
| Weighted Average Shares Outstanding (Diluted) | 569.45 Million | 572.87 Million | 592.17 Million | 577.13 Million | 578.44 Million | 576.42 Million |
| Gross Margin | 0.73 | 0.72 | 0.75 | 0.72 | 0.74 | 0.70 |
| EBIT Margin | 0.09 | 0.15 | 0.12 | - | 0.11 | 0.10 |
| Profit Margin | 0.11 | 0.13 | 0.11 | 0.11 | 0.14 | 0.08 |
| EBITDA | 75.58 Million | 131.21 Million | 168.91 Million | - | 152.13 Million | 90.74 Million |
| Earnings Before Tax Margin | 0.13 | 0.09 | 0.13 | 0.10 | 0.08 | 0.11 |
RUL
FFM
SALRY
KTCC
HAUP
AUVIQ